This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Oriental Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Young Soo Kim: Inventor in Tumor Immunotherapy.
Introduction
Young Soo Kim is an inventor based in Gyeonggi-do, South Korea. He is associated with the Korea Institute of Oriental Medicine and is named on 1 patent concerning a composition intended to inhibit tumor proliferation.
Latest Patents
Kim’s patent, “Composition for Inhibiting Proliferation of Tumor Comprising Extract as Effective Component,” describes an extract that binds to PD-L1 on cancer cells. By blocking the interaction between PD-L1 and PD-1 on T cells, the composition is intended to activate T cells and inhibit tumor growth.
The patent also reports anti-tumor immune activity in a humanized PD-1 animal model using MC38 colorectal cancer cells expressing human PD-L1. It describes a synergistic effect when the composition is administered alongside anticancer agents.
Career Highlights
Kim’s listed work connects research at the Korea Institute of Oriental Medicine with an approach to cancer immunotherapy. The patent focuses on using an extract to affect the PD-L1 and PD-1 pathway and support immune activity against tumors.
Collaborations
Hwan Suck Chung and Ji Hye Kim are identified as Kim’s coworkers.
Conclusion
Young Soo Kim’s patent describes an extract-based composition designed to activate T cells by blocking PD-L1 interactions, with reported anti-tumor activity and potential synergy with anticancer agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile